Newsroom

Why One Independent Brand Rejected Contract Manufacturing: Small-Batch Multi-Cycle Production for Clinical Actives

April 01, 2026

2026-04

Complete Elixir caps batches at 100 litres and runs multiple cycles, arguing large-batch processing degrades actives

Founder and formulator Clara Song began R&D in 2020, built a warehouse cleanroom in 2021, incorporated in 2024 and brought the current facility fully online in April 2026. Five people run it.

The company's formulation approach starts from tolerance rather than potency. Every skin has a tolerance threshold, and repeatedly irritated skin has a lower one. A single high-concentration active crosses that threshold, which is why the most aggressive formulas are often unusable on the skin that needs them most.

Instead, Complete Elixir combines multiple actives at low concentration to deliver function without provoking tolerance; carries irritation-prone actives such as retinol inside a lamellar structure; and loads comfort ingredients such as ceramides at high concentration rather than treating them as a secondary claim. A base of essential actives is built into every product, which supports a simplified all-in-one routine rather than a long layered one.

On the production side, the small-batch multi-cycle model is the direct consequence of that formulation philosophy: the company argues that large single batches degrade the actives the formulas are designed around.

The same reasoning extends to filling. Product is filled through a peristaltic pump, passing only through sterilized silicone tubing with no contact with a dispenser head - eliminating cross-contamination between products and any interaction between actives and cleaning agents or dispenser materials.

Every skin has a tolerance threshold, and skin that has been irritated repeatedly has a lower one. High-dose single actives cross that line, so the people who most need the result cannot use the product. We deliver the same function through several low-concentration actives instead, and we protect the aggressive ones inside a lamellar structure.

Clara Song, Founder and Formulator, Complete Elixir

About Complete Elixir

Complete Elixir is an independent professional skincare company based in Surrey, British Columbia. Founder and formulator Clara Song began research and development in 2020 and incorporated Complete Elixir Skincare Inc. in June 2024. The company develops and manufactures its full line at its own 941-square-foot formulation facility, which became fully operational in April 2026, using small-batch multi-cycle production rather than contract manufacturing. Complete Elixir specializes in complicated skin - acne-prone, sensitive and barrier-compromised skin - and pairs its products with professional education for estheticians. The company supplies the United States through a California distributor and is expanding into Korea, China and Israel. Learn more at completeelixir.com.